img 20251224 004722 副本
img 20251224 004753
 
 
 
 
图片1
余
20230629
640

Global Footprint & Clients

8 global R&D hubs across NA/EU/Africa/Asia; serving China Top-50 pharma and global clients (Alpharma, GSK, Novartis) with full-cycle R&D, clinical, and regulatory support.

图片2
图片1
图片4
8a5160bc45334e185e5989824f24bcba

Three VP Units

Specialized leadership across tech transfer, R&D, clinical, API, and commercialization.

gemini generated image mjzjj8mjzjj8mjzj

VP – Tech Transfer

Technology commercialization & partnerships

gemini generated image moeg0omoeg0omoeg

VP – PDS (Drug Dev.)

Formulation/API development & regulatory support

gemini generated image sx8osnsx8osnsx8o

VP – CRO (Clinical Research)

Trial execution & RWS/RWE

Connect with CHG. We tailor solutions across clinical, hospital ops, specialty/telehealth and rehab/medical tourism, with a dedicated point of contact.

AI